In this brief The Situation
Mind Meeting Group Intelligence Brief | CDA-AMC | May 2026

The Coordination Deficit

Executive Summary

Canada's medical imaging system is absorbing an estimated $55 million annually in directly audited, unrecoverable costs from missed CT and MRI appointments -- staff paid, equipment running, slots wasted.1 CDA-AMC's March 2026 national survey of 85 imaging sites confirmed that 88% of sites using proactive mitigation strategies report positive outcomes, against 35% for reactive ones.2 The gap between what works and what most of the system does is not a knowledge failure. It is a coordination failure. The actors who could close it have no standing forum to produce a committed decision that crosses their organizational boundaries.

The challenges that follow are not primarily clinical, technological, or analytical problems. In each case, the actors who must move hold conflicting incentives, no standing forum exists to produce a binding outcome, and standard approaches have already reached their limits. CDA-AMC's March 2026 report is the most comprehensive pan-Canadian evidence synthesis on this challenge ever assembled. What it leaves open is what comes next -- and that question is what this brief addresses. This is one of a series MMG prepares independently for organizations where structured convening is the right intervention and the cost of the status quo is measurable.

The Situation

A Solvable Problem That the System Has Failed to Solve

Canada's medical imaging no-show challenge has been visible for years. CDA-AMC's March 2026 national survey of 85 imaging sites -- drawing responses from every province and territory -- found that average no-show rates across the four major modalities were 5% for CT, 5% for MRI, 4% for X-ray, and 7% for ultrasound. Framed in aggregate, those numbers can appear manageable. They are not. The averages conceal the structural reality: some responding sites in Quebec reported CT no-show rates between 21% and 25%, while 33% of responding sites in the territories reported CT no-show rates exceeding 25%.4 For MRI, all responding sites in the territories reported rates in the 16% to 20% range. For ultrasound, 25% of responding sites in both Quebec and the territories reported rates over 25%. The national average is a blended figure that masks localized system failures of a different order of magnitude.

The cost embedded in those rates is substantial. Canada conducts approximately 6.42 million CT exams annually. At the survey's national average CT no-show rate of 5%, the system loses roughly 321,000 CT appointments per year. At a sunk cost of $128.31 per missed appointment -- the directly audited staffing and overhead absorbed regardless of patient attendance -- the CT component alone accounts for approximately $41 million. Applying the same rate to Canada's 2.2 million annual MRI exams adds approximately $14 million, bringing the combined CT and MRI total to approximately $55 million in directly audited, unrecoverable costs annually. This does not include ultrasound or X-ray. It does not include the downstream cost of conditions that deteriorate during the rescheduling queue. And it does not include the broader economic toll: a 2022 report by the Canadian Association of Radiologists and Deloitte estimated that diagnostic imaging delays generate $17.9 billion in annual employment income loss and $64.2 billion in annual GDP loss, with an average personal economic burden of $1,017 per patient.5 In Canada, median wait times are already 84 days for an MRI and 66 days for a CT scan -- a backlog that every missed appointment makes worse.7

The measurement problem compounds the operational one. The CDA-AMC survey found that 26% of responding imaging sites track no-shows by no formal or informal method at all.3 A quarter of the system is, in the most literal sense, blind to its own capacity loss. Administrators who cannot measure the problem cannot make the case for resources to address it, cannot evaluate whether interventions are working, and cannot contribute data to national benchmarking. The measurement gap and the performance gap reinforce each other in a cycle that unilateral action at the site level cannot break.

CDA-AMC's March 2026 report is the most comprehensive pan-Canadian evidence synthesis on this challenge to date. It surveyed leaders from every province and territory, reviewed the literature, and held patient engagement sessions with 18 individuals directly affected by no-shows. It confirmed that proactive strategies work -- 88% of sites using them report positive outcomes -- and that reactive strategies largely do not, with only 35% reporting the same. It documented the contributing factors across five overlapping categories: logistical, access and infrastructure, psychological and behavioural, cognitive and informational, and demographic. The report creates a moment. CDA-AMC has produced the most authoritative evidence base on this challenge that Canada has ever assembled. What it leaves open -- the question this brief addresses -- is what comes next.

The Problem

Why Every Stakeholder Has a Piece of the Solution and None Has the Whole Thing

The no-shows challenge in Canadian medical imaging is routinely framed as a patient compliance problem, a technology problem, or a funding problem. Each of those framings captures something real. None captures enough to produce a durable solution. The reason is structural: the actors who each control one part of the solution do not control the others, operate under incentive structures that actively work against coordinated action, and have no standing mechanism for producing a committed decision that crosses organizational boundaries.

The actors who each control one piece of the solution operate under incentive structures that work against coordinated action, and have no standing mechanism for producing a committed decision that crosses organizational boundaries.

Why no single actor can close this gap

  • Referring physicians -- control patient expectation-setting and referral data quality, but have no financial incentive to track whether patients attend downstream appointments and receive no notification when they miss.
  • Imaging schedulers -- control booking workflows and reminder systems, but are incentivized to maximize throughput, not redesign process.
  • Hospital CFOs -- control whether departments can invest in navigation staff or scheduling tools, but hospital budgets structurally separate capital from operational expenditure, blocking approvals that cross that line.
  • Health IT and EMR vendors -- control the interoperability architecture that would enable closed-loop referral tracking, but face economic incentives to limit data portability.
  • Indigenous health organizations and patient navigators -- hold community trust and logistical capacity to address the highest no-show rates, but their programs are chronically underfunded and structurally excluded from institutional planning.
  • Provincial health authorities -- hold the funding and mandate authority to require standardized tracking and reporting, but operate across boundaries that separate hospital funding from primary care, making integrated pathway design difficult to authorize.

The CDA-AMC report's patient engagement sessions were revealing on this point. Participants consistently identified that the factors contributing to no-shows were interconnected and required a coordinated response: transportation barriers, childcare responsibilities, "scan-xiety," fragmented reminder systems, cultural and language barriers, and the absence of system navigators -- each one addressable in isolation, none of them sufficient without the others moving simultaneously. Participants noted that many were unaware support services even existed. The knowledge that proactive strategies work does not, on its own, change the structural conditions that make passive strategies the default for most of the system.

The Dimensions

Eight Interdependent Problems That Cannot Be Solved in Sequence

No. Dimension Name What makes it unsolvable by any single actor
1 Patient Communication and Health Literacy Schedulers control reminder systems; referring physicians control initial patient education; IT vendors control digital channels. The CDA-AMC report found that tailored, multi-modal, plain-language reminders are most effective -- but no single actor controls the full communication chain, and it breaks at every handoff. The majority of sites still rely on a single automated reminder.
2 Scheduling System Design Department managers set booking policy; IT vendors build scheduling interfaces; provincial authorities set volume targets that drive the throughput incentives managers optimize for. The CDA-AMC survey found that reduced lead times and self-scheduling tools significantly improve attendance -- but deploying them requires all three actors to move, and they have no forum in which to do so.
3 Social Determinants and Access Barriers Transportation subsidies, childcare accommodation, parking access, and flexible scheduling blocks are each controlled by different funding streams and organizations. The CDA-AMC report found that financial barriers and distance from clinic are primary drivers of missed appointments -- particularly in rural and remote settings -- but integrating logistical support into the referral pathway requires health authorities, navigators, and institutions to co-design architecture that none of them currently owns alone.
4 Clinical Pathway Fragmentation The CDA-AMC survey identified duplicate referrals -- patients completing scans elsewhere while original bookings go unfilled -- as a documented source of no-shows that no site-level intervention can address. Closing the referral loop requires IT vendors to enable interoperability, referring physicians to adopt new workflows, and health authorities to mandate standards across jurisdictions with divergent infrastructure and budgets.
5 Data and Accountability Infrastructure 26% of responding imaging sites in the CDA-AMC survey track no-shows by no method at all. Standardizing measurement requires provincial health authorities to mandate it, CIHI to define common metrics, and institutions to build reporting workflows -- none of which can proceed unilaterally, and none of which has been coordinated across the system.
6 Equity and Population-Specific Factors The CDA-AMC report documented that rates exceeding 25% are concentrated in remote communities and among Indigenous, racialized, and low-income populations. The patient engagement sessions identified cultural and language barriers, system navigation gaps, and trauma as primary drivers. Addressing these requires Indigenous navigators, institutional administrators, and provincial funders to redesign care pathways together -- and navigator programs are chronically underfunded and excluded from the planning processes where that redesign would happen.
7 Organizational Culture and Staff Capacity The CDA-AMC survey found that despite high interest in automated reminder platforms, many sites lack the technology to implement them, citing cost, workflow constraints, and privacy compliance as barriers. Hospital budget silos separate capital from operational funding, blocking the staff, software, and workflow investments that would reduce no-shows -- and dismantling those silos requires CFOs, administrators, and provincial funders to authorize changes that no department can make independently.
8 Technology and Innovation Adoption The CDA-AMC report identifies predictive AI tools -- capable of identifying high-risk patients before they miss -- as an emerging strategy with documented effectiveness. Adoption across the Canadian system remains minimal, blocked by procurement silos, privacy frameworks, and interoperability gaps. Deployment requires vendors, procurement authorities, privacy officers, and clinical leaders to align across organizations that have no standing forum for that conversation.
The Diagnosis

Why Conventional Approaches Won't Close the Gap

Why Process Is the Variable That Matters

When a challenge of this visibility and documented cost persists despite an extensive evidence base on what works, the instinct is to commission more research, convene another advisory panel, or fund another site-level pilot. The research on that instinct is unambiguous: the quality of the decision-making process predicts outcomes far more powerfully than the depth of the analysis that feeds it. In a multi-stakeholder challenge where the actors who must move hold conflicting incentives and no standing forum exists, better analysis delivered through the wrong process produces the same result as worse analysis delivered through the wrong process.

Process beats analysis six to one.

A landmark McKinsey study of 1,048 major organizational decisions found that decision-making process quality predicted strategic outcomes six times more powerfully than the depth or quantity of the analysis -- and that top-quartile process organizations earned a 6.9 percentage-point performance premium over bottom-quartile ones. For a health system losing an estimated $57 million annually in CT waste, the implication is direct: a better analytical case for action is not what is missing.

Unstructured deliberation produces noise, not consensus.

In Noise: A Flaw in Human Judgment, behavioral scientists Daniel Kahneman, Olivier Sibony, and Cass Sunstein document that when expert decision-makers engage with identical scenarios, their judgments vary by a median of 44 to 55%. In multi-stakeholder health system forums -- where referring physicians, hospital administrators, provincial funders, and IT vendors each bring different institutional incentives to the same evidence -- unstructured deliberation does not converge. It produces the appearance of consensus while leaving the underlying commitments unmade.

AI commoditizes analysis -- it doesn't replace the need for structured judgment.

Peer-reviewed research from Michigan, UT Austin, and INSEAD found that AI can now generate and evaluate complex strategic plans at a level comparable to experienced analysts. When every actor in the ecosystem has access to equivalent analytical capability, the differentiator becomes how well those actors deliberate and decide together. The no-shows challenge is not an information problem. The CDA-AMC report itself demonstrates that the evidence is available and broadly understood.

Volatility amplifies every bias precisely when pressure is highest.

In complex, multi-constraint health system environments, cognitive shortcuts become more dangerous: anchoring on familiar interventions, groupthink within institutional silos, and overconfidence in site-level solutions intensify precisely when leaders feel most urgency to act. Structured process -- designed specifically to surface and manage these dynamics -- is the only reliable buffer. Without it, the most visible stakeholder in the room sets the agenda, and the actors whose commitment is most critical stay silent.

The implication for this specific challenge is direct. The CDA-AMC report has established that the problem is real, that the contributing factors are multidimensional, and that proactive and coordinated strategies outperform reactive and siloed ones. What it cannot do -- and what no report can do -- is produce the committed decisions that require multiple independent actors to move simultaneously. A deliberately designed process that brings the right actors into the same room, with the right framing, at the right moment, is what converts that evidence into binding action.

The Village

Who Needs to Be in the Room

Stakeholder Category Role in the Problem Why their absence stalls the solution
Imaging Department Managers and Schedulers Control booking workflows, reminder systems, overbooking parameters, and local no-show tracking. The CDA-AMC survey found that 88% of sites use proactive strategies, but implementation quality varies widely and most rely on passive automated reminders. No technology or policy solution survives if the personnel who manage the daily appointment ledger have not co-designed it. Their absence means any strategy produced will fail at the point of execution.
Referring Physicians (Family Doctors and Specialists) Control patient expectation-setting, communication of clinical urgency, referral data quality, and the closed-loop feedback that would alert them when patients miss. The CDA-AMC survey found that 25% of sites observe higher no-show rates from family doctor referrals, and there is no systematic mechanism for notifying referring physicians when their patients do not attend. If the clinical handoff is broken, downstream imaging interventions are undermined before they begin. Referring physicians must co-own the solution or they will not change the practices that generate the problem.
Hospital Administrators and CFOs Control institutional resource allocation, budget structure, and the authorization to invest in operational innovations -- navigation staff, AI scheduling tools, workflow redesign -- that reduce no-shows. The CDA-AMC report found that many sites lack access to automated reminder platforms specifically due to cost and budget constraints. Strategic solutions die in the procurement phase without explicit financial authorization. Capital-versus-operational budget silos are an institutional design problem that only executives can restructure.
Provincial Health Authority Representatives Control macro-level funding, performance standards, and the mandate authority that could require sites to track, report, and be accountable for no-show rates. The CDA-AMC report found 26% of sites track nothing -- a gap that only provincial mandate can systematically close. Without provincial mandate and funding alignment, improvements remain site-specific and do not accumulate into system-level change. Provincial representatives are the only actors who can establish the accountability infrastructure the system currently lacks.
Indigenous Health Organizations and Patient Navigators Hold community trust, cultural safety expertise, and logistical capacity to address the 25%-plus no-show rates in Indigenous, remote, and northern communities. Patient engagement sessions in the CDA-AMC report consistently identified navigator availability as a priority -- and the absence of navigators as a primary driver of missed appointments for equity-deserving populations. A strategy that does not center Indigenous community co-design will not resolve the most extreme statistical outliers in the national data. Navigator programs are also chronically underfunded and must have structural budget commitments authorized by the actors above in order to function.
Health IT and EMR Vendors Control the software architecture, interoperability standards, and reminder platform integration that would enable closed-loop referral tracking and automated high-risk patient identification. The CDA-AMC report identified lack of IT infrastructure as a primary barrier to deploying even basic automated reminder systems at many sites. Systemic coordination is technically impossible without the active cooperation of IT vendors. Their absence from the design process means solutions are built around their constraints rather than through their capabilities.
Patient Advocacy Organizations Represent the patient populations most affected by diagnostic delays, and provide the accountability mechanism that sustains political pressure for durable change. The CDA-AMC patient engagement sessions found that patients themselves are often unaware that missed appointments have system-wide consequences -- a communication gap that advocacy organizations are positioned to address. Without patient voice in the room, solutions are designed for a patient population that was not consulted, and the behavioural design assumptions embedded in scheduling and reminder systems remain untested against lived experience.
Radiologists and Medical Radiation Technologists Establish clinical urgency criteria, protocoling requirements, and preparation instructions -- factors the CDA-AMC report identifies as direct contributors to no-shows when they are poorly communicated or overly rigid. Radiologists also set the parameters for overbooking tolerance and same-day scheduling flexibility. Clinical buy-in from radiologists is required to authorize more flexible scheduling protocols. Without it, operational solutions proposed by administrators or IT will be blocked at the clinical authority level.
Primary Care Networks Coordinate care at the community level and have the capacity to implement standardized e-referral practices and high-risk patient tracking that individual family physicians cannot manage alone. The CDA-AMC survey found that referral source influences no-show rates -- addressing that requires coordination at the network level, not the individual physician level. Primary care networks bridge the gap between individual referring physicians and large hospital systems. Without their participation, improvements in the referral-to-imaging handoff remain dependent on individual physician behaviour change rather than system redesign.
Health System Researchers and Academics Provide the evaluation frameworks and population health data required to assess whether interventions are working, which the CDA-AMC report identifies as a significant gap -- most strategies reported by survey respondents have not been formally evaluated. Research bodies provide the accountability and evidence-generation infrastructure that converts a one-time intervention into a learning system. Without them, the workshop produces commitments that cannot be evaluated for effectiveness or scaled.
The Engagement

What Structured Convening Delivers

A Mind Meeting is an intensive three-day solving sprint designed specifically for challenges where progress depends on the simultaneous commitment of actors who sit outside any single organization's authority. It is not an advisory board, a consultation process, or a facilitated workshop in the conventional sense. It is built around a specific challenge -- one where the actors who must move hold conflicting incentives, where no standing forum exists to produce a binding outcome, and where standard approaches have already reached their limits. The no-shows challenge meets every one of those criteria, and the CDA-AMC report documents why at length.

The preparation phase identifies which actors must be in the room, how the challenge must be framed to make productive deliberation possible, and what decisions need to emerge by the end of the session. For a challenge this structurally complex, framing is not a communications decision -- it is a design decision. The CDA-AMC report's own finding that the contributing factors "often overlap, creating a complex network of influences" is precisely why generic workshop formats fail: they bring actors together without the design discipline required to navigate that complexity toward a committed outcome. MMG facilitates the session itself -- managing the dynamics that cause multi-stakeholder deliberations to produce recommendations rather than decisions -- and structures the follow-through that translates outcomes into accountable next steps with named owners across the stakeholder groups.

MMG has done this in Canadian medical imaging before. In October 2023, MMG convened a 28-person virtual workshop for Eisai Canada on the specific question of MRI access for early Alzheimer's patients -- bringing together radiologists, MR technologists, neurologists, patient advocates, policy consultants, and a person living with dementia. Working across six topic teams over three days, participants identified 180 distinct issues, generated 125 candidate solutions, and converged on 19 prioritized recommendations. The process surfaced something more important than the recommendations: participants consistently noted that the complexity of the problem extended well beyond MRI capacity itself -- into workforce, funding fragmentation, advocacy gaps, and care model design -- dimensions that no single stakeholder had previously seen whole. That is precisely what structured multi-stakeholder convening is designed to reveal.

What CDA-AMC leaves the process with is specific: a committed decision architecture, a clear allocation of responsibility across the actors present, and a defined condition for reconvening if the environment changes. No open questions that reset the conversation. No advisory outputs that require another round of internal approval before anything moves. For CDA-AMC, whose March 2026 report represents the most comprehensive evidence synthesis on this challenge Canada has produced, the question is not whether the evidence is sufficient to act. It is whether the process exists to convert that evidence into binding commitments across the actors who must move simultaneously. That process is what a Mind Meeting is designed to deliver.

CDA-AMC's position in the Canadian health system makes it the natural convener for this challenge. It is pan-Canadian in mandate, independent in standing, and credible to every stakeholder category that must be in the room -- from provincial health authorities to patient advocacy organizations to clinical specialists. It produced the evidence. It engaged the patients. It has the relationships and the institutional authority to convene actors who would not assemble for a narrower sponsor. The March 2026 report is not the conclusion of a research cycle. It is the foundation for a convening.

The Choice

How MMG Compares

Mind Meeting Conference / Advisory Panel
Problem Definition Researched before the room convenes -- no-show drivers, equity gaps, interoperability failures, and stakeholder incentive conflicts are mapped and built into the session design Terms of reference are set by the organizing body; structural drivers of the challenge are documented in background materials but rarely built into the design of the process itself.
Who's in the Room The full village of constraint-owners -- schedulers, referring physicians, hospital CFOs, Indigenous navigators, IT vendors, provincial funders, patient advocates, and researchers -- together, in working mode Expert presenters and invited delegates; implementation actors are often absent or attending in listening mode rather than decision mode, and the actors who must act on the outcome are rarely all present simultaneously.
Output A committed decision architecture with named owners across stakeholder groups and defined accountability for next steps Proceedings, position papers, and working group reports -- credible inputs to future policy or practice that require a separate organizational process to convert into action.
Execution Commitment Built in -- participants co-create the strategy they must implement, which is the primary mechanism through which commitment is generated None structurally; attendees return to their organizations with recommendations, not obligations, and the gap between what the room agreed on and what any actor does next is not addressed by the process itself.
Trade-off Discipline Forced -- real choices made between competing approaches, resource allocations, and sequencing decisions in a room where all the actors affected are present Low; conference formats are designed to surface perspectives and build documented consensus, not to force genuine choices between competing approaches in a room where all affected actors must live with the outcome.
Speed to Decision Three days to an aligned, pressure-tested action plan with co-owned accountability across the stakeholder ecosystem Fast to produce a synthesis document; slow to produce coordinated action, particularly across organizations that each require their own internal approval to act on recommendations they did not co-create.
Research Output / Academic Publication A structured multi-stakeholder workshop generates primary qualitative data -- mapped issues, candidate solutions, prioritized recommendations, and post-session survey results -- that meets the methodological standards for peer-reviewed publication. A Mind Meeting can serve as the research methodology for an academic paper in a medical or health policy journal. Proceedings and consensus statements are publishable in summary form, but they reflect curated expert opinion rather than primary data from a structured research methodology. The resulting publications tend toward commentary or position papers rather than original research.
Next Steps

Book a Discovery Call

CDA-AMC's March 2026 report established something important: the evidence base for action on medical imaging no-shows now exists at a national scale, built from responses across every province and territory, validated through patient engagement, and synthesized into a framework that is credible to every stakeholder in the ecosystem.

The other half -- the process that converts evidence into committed action across actors who have no standing forum for that commitment -- does not yet exist. More data will not supply it. More advisory engagement, run stakeholder by stakeholder, will not produce it. What converts a well-documented coordination failure into a co-owned solution is a deliberately designed process that brings the right actors into the same room at the right moment, with the framing and the structure required to produce decisions rather than recommendations.

That is what Mind Meeting Group builds. To learn more, book a discovery call with Mark McCarvill at the link below.

About the Author

Mark McCarvill is the Founder and Principal Facilitator of Mind Meeting Group, a Vancouver-based consulting firm specializing in complex, multi-stakeholder strategy. He has facilitated over 100 decision-grade workshops across life sciences, federal government, not-for-profit, and commercial sectors, aligning more than 3,000 leaders and stakeholders. MMG's methodology is grounded in complexity science, organizational behaviour research, and fifteen years of practice in high-stakes strategic alignment. In medical imaging specifically, MMG has convened multi-stakeholder workshops on MRI access challenges in the Canadian health system, working with radiologists, technologists, patient advocates, and policy experts to surface complexity and generate coalition-ready recommendations.

Notes
  1. Source: MMG calculation using Canadian-sourced data throughout. CT component: approximately 6.42 million CT exams performed annually in Canada (CADTH). At the national average no-show rate of 5% (CDA-AMC survey, March 2026, n=85 sites), this yields approximately 321,000 missed CT appointments × $128.31 = ~$41M. MRI component: 2,214,157 publicly funded MRI exams performed in Canada in 2022–23 (Canadian Medical Imaging Inventory 2022–2023, CADTH, August 2024). At a 5% no-show rate, this yields approximately 110,708 missed MRI appointments × $128.31 = ~$14M. Combined total: approximately $55M. The $128.31 sunk cost per missed appointment is derived from the Ontario Auditor General’s 2018 audit of MRI and CT scanning services, which recorded $6.2 million in idle staffing costs across 48,320 missed MRI appointments in Ontario in 2017–18. This figure represents a conservative floor — it captures only direct staffing and overhead costs absorbed regardless of patient attendance. It does not account for opportunity costs, downstream care impacts, or jurisdictions where no-show rates exceed 25%.
  2. Source: CDA-AMC, No-Shows in Medical Imaging Departments in Canada: Trends and Mitigation Strategies, March 2026. Key Messages, p. 3; confirmed in survey results, pp. 25 and 35. Among 85 responding sites, 75 (88%) reported using proactive strategies; 30 (35%) reported using reactive strategies.
  3. Source: CDA-AMC, No-Shows in Medical Imaging Departments in Canada, March 2026, p. 13. Of 85 responding sites, 22 (26%) indicated they did not track no-shows by any method.
  4. Source: CDA-AMC, No-Shows in Medical Imaging Departments in Canada, March 2026, pp. 15–16. Survey of 85 imaging sites across all provinces and territories.
  5. Source: Canadian Association of Radiologists (CAR) and Deloitte, Improving Access to Lifesaving Imaging Care for Canadians, 2022.
  6. Source: CDA-AMC, No-Shows in Medical Imaging Departments in Canada, March 2026, p. 42 and Figure 30, p. 61. Survey of 85 sites; 21 (25%) reported higher no-show rates from family doctor referrals; 37 (44%) did not know.
  7. Source: Canadian Association of Radiologists (CAR) and Deloitte, Improving Access to Lifesaving Imaging Care for Canadians, 2022. Same source as note 5.